TOP STORIES

• BUSINESS Hib Vaccine Wind-Up, Development Flop Trigger GSK, Daiichi Sankyo to Shutter JV
  November 15, 2018

• REGULATORY Chuikyo Agrees on October 2019 Drug Price Revision for Tax Hike, but Final Call Is Up to Govt
  November 15, 2018

• REGULATORY Maviret Faces 25% Price Slash in Quarterly Review
  November 14, 2018

• BUSINESS GSK, Daiichi Sankyo Dissolve Vaccine JV
  November 14, 2018

• REGULATORY Novartis’ SMA Gene Therapy Filed in Japan on Nov. 1 after US, EU; What Will Happen to Sakigake Status?
  November 13, 2018

• BUSINESS Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
  November 13, 2018

• BUSINESS Takeda: De-facto Vote on Shire Deal Set for Dec. 5
  November 12, 2018

• BUSINESS Japan Is Top Strategic Market for Biogen: CEO
  November 12, 2018

• ORGANIZATION 7 EFPIA Companies Revised R&D Strategies after April Pricing Overhaul: Survey
  November 9, 2018

• REGULATORY LDP Health Bigwigs Agree to Push for October 2019 Revision
  November 9, 2018

• REGULATORY MHLW Pitches “Tiered Model” for CEA Price Tweak, but Faces Chuikyo Opposition
  November 8, 2018

• REGULATORY FY2019 Tax Reform Debate Going into Full Swing; Will Pharma Industry Win Expansion in R&D Credit?
  November 7, 2018

• ORGANIZATION Wrong Policies Could Drive Investments Out of Japan amid China’s Rise, PhRMA Int’l Advocacy Chief Warns
  November 6, 2018

• BUSINESS Balancing Act: All Eyes on Nesp Biosame Pricing before June 2019 Listing, Biosimilars to Follow in November
  November 5, 2018

• BUSINESS 8 Major Drug Makers See Flat Sales in 1st Half; Overseas Growth Continues to Compensate for Slumping Japan Revenue
  November 5, 2018

• REGULATORY LDP’s Eto Study Group Opposes 2-Stage Revision in 2019
  November 2, 2018

• REGULATORY Chuikyo Leaning towards Drug Price Revision in October 2019 in Conjunction with Tax Hike
  November 1, 2018

• REGULATORY Infection Specialist Proposes to Set Up Vaccination Council within Cabinet Office
  October 31, 2018

• BUSINESS Shionogi Chief Confident about 70% Market Share for Xofluza in Japan
  October 30, 2018

• ORGANIZATION Limit CEA Application to Premium-Given Drugs with Big Sales: EFPIA Japan Officials
  October 29, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• 141
• …
• Next ›
• 最終 »